These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 38215151)

  • 1. Exploring the landscape of drug resistance in gastrointestinal cancer immunotherapy: A review.
    Yao N; Li W; Duan N; Xu G; Yu G; Qu J
    Medicine (Baltimore); 2024 Jan; 103(2):e36957. PubMed ID: 38215151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer-Current Treatment Options and Future Perspectives.
    Koustas E; Trifylli EM; Sarantis P; Papadopoulos N; Karapedi E; Aloizos G; Damaskos C; Garmpis N; Garmpi A; Papavassiliou KA; Karamouzis MV; Papavassiliou AG
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
    Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy resistance in esophageal cancer: Possible mechanisms and clinical implications.
    Fang P; Zhou J; Liang Z; Yang Y; Luan S; Xiao X; Li X; Zhang H; Shang Q; Zeng X; Yuan Y
    Front Immunol; 2022; 13():975986. PubMed ID: 36119033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel immunotherapies for breast cancer: Focus on 2023 findings.
    Lan HR; Chen M; Yao SY; Chen JX; Jin KT
    Int Immunopharmacol; 2024 Feb; 128():111549. PubMed ID: 38266449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer.
    Wang X; Zhou L; Wang H; Chen W; Jiang L; Ming G; Wang J
    Cancer Med; 2023 Nov; 12(21):20573-20589. PubMed ID: 37860928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy revolutionizing brain metastatic cancer treatment: personalized strategies for transformative outcomes.
    Li T; Sun S; Li Y; Zhang Y; Wei L
    Front Immunol; 2024; 15():1418580. PubMed ID: 39136027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The State of Immunotherapy in Hepatobiliary Cancers.
    Ilyas FZ; Beane JD; Pawlik TM
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression.
    Saleh R; Elkord E
    Semin Cancer Biol; 2020 Oct; 65():13-27. PubMed ID: 31362073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing Colorectal Cancer Immunotherapy: The Pivotal Role of Ferroptosis in Modulating the Tumor Microenvironment.
    Li Y; Cheng X
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
    Chung C
    Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANO1-Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer-Associated Fibroblasts.
    Jiang F; Jia K; Chen Y; Ji C; Chong X; Li Z; Zhao F; Bai Y; Ge S; Gao J; Zhang X; Li J; Shen L; Zhang C
    Adv Sci (Weinh); 2023 Aug; 10(24):e2300881. PubMed ID: 37341301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance.
    Yao L; Wang Q; Ma W
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications.
    Wang DK; Zuo Q; He QY; Li B
    Front Immunol; 2021; 12():705999. PubMed ID: 34447376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoantigens and their clinical applications in human gastrointestinal cancers.
    Eshkiki ZS; Agah S; Tabaeian SP; Sedaghat M; Dana F; Talebi A; Akbari A
    World J Surg Oncol; 2022 Sep; 20(1):321. PubMed ID: 36171610
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Li L; Li M; Jiang Z; Wang X
    Cells; 2019 Jul; 8(7):. PubMed ID: 31277418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming Resistance Mechanisms to Immune Checkpoint Inhibitors: Leveraging the Anti-Tumor Immune Response.
    Coschi CH; Juergens RA
    Curr Oncol; 2023 Dec; 31(1):1-23. PubMed ID: 38275827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks.
    Meng L; Wu H; Wu J; Ding P; He J; Sang M; Liu L
    Cell Death Dis; 2024 Jan; 15(1):3. PubMed ID: 38177102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MT1G, an emerging ferroptosis-related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer.
    Cheng B; Lai Y; Huang H; Peng S; Tang C; Chen J; Luo T; Wu J; He H; Wang Q; Huang H
    Environ Toxicol; 2024 Feb; 39(2):927-941. PubMed ID: 37972062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.